Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Awake Nasotracheal Fiberoptic Intubation Sedation Techniques Comparison
IRCT201208061674N4Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of remifentanil, ketamine and propofol in temporomandibular disorder (TMD) (3 arms), sponsored by Shiraz University of Medical Sciences. Started Nov 2012; status: completed.
02
Drugs
remifentanilketaminepropofol
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on IRCT201208061674N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208061674N4.